LOADING
Comparing Apple Inc (AAPL) and Pfizer Inc (PFE) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | AAPL | PFE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $4.85T | $158.0B |
| P/E Ratio | 38.1 | 36.5 |
| Forward P/E | 33.9 | 9.5 |
| PEG Ratio | 2.61 | 12.68 |
| EPS | $8.71 | $0.76 |
| Revenue Growth (YoY) | 16.4% | 2.6% |
| Profit Margin | 27.6% | 6.8% |
| Return on Equity | 148.8% | 5.0% |
| Dividend Yield | 0.32% | 6.22% |
| Beta | 1.08 | 0.30 |
| 52-Week High | $344.27 | $29.21 |
| 52-Week Low | $234.16 | $22.03 |
| Volume | -- | -- |
Apple Inc is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Apple Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.